Key statistics
On Thursday, Aldeyra Therapeutics Inc (137:FRA) closed at 4.47, -22.78% below its 52-week high of 5.79, set on Sep 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.47 |
---|---|
High | 4.47 |
Low | 4.47 |
Bid | 4.55 |
Offer | 4.64 |
Previous close | 4.47 |
Average volume | 644.00 |
---|---|
Shares outstanding | 59.55m |
Free float | 48.82m |
P/E (TTM) | -- |
Market cap | 283.46m USD |
EPS (TTM) | -0.7538 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 07:20 GMT.
More ▼
Press releases
- Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
- Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference
- Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
- Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
- Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
More ▼